Infectious Disorders of the Lung Parenchyma. Matthew L. Paden, MD Pediatric Critical Care Fellow Emory University Children’s Healthcare of Atlanta at Egleston. Objectives. Worldwide epidemiology of the problem Review common etiologies Discuss empirical and disease specific treatment.
Matthew L. Paden, MD
Pediatric Critical Care Fellow
Children’s Healthcare of Atlanta at Egleston
Geographically-based evaluation of multi-drug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003-2004). Int J Antimicrob Agents. 2006 Dec;28(6):525-31.
Percent of organisms tested that have intermediate or resistant sensitivity patterns
* Not adjusted for inducible resistance
So which to choose?
dyspnea 83%; coryza 88%; fever 52-92%)
Rex, 1994; Phillips 1997; Nguyen, 1995; Anaissie, 1998
Flucon Itra AmB 5-FC
C. albicans S S S S
C. parapsilosis S S S S
C. tropicalisS S S S
C. glabrata SDD-R SDD-R IS
C. krusei RSDD-R I-r I-R
C. lusitaniae S S-SDDR R